In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
about
Translating Treg Therapy in Humanized MiceRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationRegulatory T cells in transplantationCell therapy to induce allograft tolerance: time to switch to plan B?Regulatory B cells: an exciting target for future therapeutics in transplantationRegulatory T-cell therapy in transplantation: moving to the clinicEx vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull miceTolerance in liver transplantation: Biomarkers and clinical relevanceImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisDeveloping in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's diseaseCD45RA distinguishes CD4+CD25+CD127-/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus mediated inhibition of suppression.A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation.Human allograft rejection in humanized mice: a historical perspectiveIL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized MiceUnique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.T-cell co-stimulatory blockade in kidney transplantation: back to the benchSpatial differences in the presence of FOXP3+ and GranzymeB+ T cells between the intra- and extravascular compartments in renal allograft vasculopathy.In vivo SPECT reporter gene imaging of regulatory T cells.A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejectionClues to immune tolerance: the monogenic autoimmune syndromesLong-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2.Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival.Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cellsNeutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cellsUse of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesT-cell activation and transplantation tolerance.Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells.Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells.A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3.Inhibition of histone methyltransferase EZH2 ameliorates early acute renal allograft rejection in ratsPeripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantationIn vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.Blocking MHC class II on human endothelium mitigates acute rejection
P2860
Q26772335-88093FAF-62FF-4648-9729-CD75143F2C7BQ26784460-B5C083FA-4CAD-4367-87DD-B5046B03C250Q27011620-4B61FDF8-110A-4E68-B84B-8E34ADAB4056Q27013040-E046958E-1019-4C87-82FB-1FF8DBC83BE2Q27015093-C9913CA5-98A3-4518-BC42-1B9BB54F0BB7Q27025869-9425AF70-7EFF-4E8A-BD74-4F4CE2F8B113Q27318356-FE96EA45-ED20-4FED-BC43-6016716B7824Q28079523-52526D7E-552B-434D-8452-5CF90F5BBCC9Q28084366-83EA7BBD-369B-4507-A3E8-35BCAF821CC5Q28601365-887A167A-ED24-4456-874F-17FFDB7C868EQ30489628-5DC6872B-2ECC-4AD0-9252-5A83F9557253Q30826185-B5CACDB5-1FFF-4261-8DAF-C882D31EDBEAQ33577374-AFEA5307-E399-48F2-A9C3-5E6C5DEBF4F2Q33586165-DE61A73B-DDE2-47E0-8100-395B496897F6Q33829220-27D87ADB-C6B8-4D60-B6B1-F09C613B5764Q33873078-F120E948-52D9-45CE-851D-4841A491CE1DQ33873655-8003344C-AFBA-4613-A4D7-A81555FC58DCQ34063607-AD4CB215-B578-4751-8AF1-C28EACF14703Q34127817-4BE4B968-E69D-4496-B8C8-28758D38F96AQ34438306-273252E9-1A11-4296-AD01-9DFDF48E3EDCQ34440616-3D842566-7249-44DB-9236-8CF30B67A869Q34525728-58F482E1-AB90-4524-81A6-579C9B7BF788Q34586781-3A012943-C446-4580-AA33-E8F662F334FBQ34634834-0E5BF813-60E7-4748-AA9A-2397BC1B01F2Q34742199-3B0542EF-B352-47FA-83A8-47E19DBA8184Q35465343-492107CE-FF91-4EC5-860F-8C03A5A5258BQ35613184-B23D5FF1-F598-4F84-B004-45A02EB8768CQ35738486-7FB2E44F-78A1-4D73-9D01-BF1CE7023649Q35803977-DBB3EDFA-2CC6-4C9E-882B-933DA03D1AC7Q35875359-E81DB868-F5AB-4297-BFCB-4349EC7AA57BQ35902903-8C48AD8B-CD2F-4525-B736-F4D1B59B51F2Q35928393-9BC08B94-4C08-4AEA-ABE6-C401C840FF99Q35945436-75FEC366-46E6-42AC-A0E1-6B3EA7BACC63Q36029353-5CB4A4F3-3E80-40F3-A1AF-DF7F3945E471Q36057989-726A116F-BB6A-4091-840F-266AEC37FAD8Q36175311-07FAAEFC-59B7-4F13-8439-688D80E90814Q36183387-CAB22432-B294-437D-AAD1-996B5F163596Q36350059-B49FEDB4-003A-482C-8F94-0D7D6D2730E7Q36537036-0E49031D-2E9E-4041-A672-BBF79C1F7E46Q36588477-675419B0-EF0C-4E33-A30F-4E4CE039FDDD
P2860
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vivo prevention of transpla ...... nded human regulatory T cells.
@ast
In vivo prevention of transpla ...... nded human regulatory T cells.
@en
In vivo prevention of transpla ...... nded human regulatory T cells.
@nl
type
label
In vivo prevention of transpla ...... nded human regulatory T cells.
@ast
In vivo prevention of transpla ...... nded human regulatory T cells.
@en
In vivo prevention of transpla ...... nded human regulatory T cells.
@nl
prefLabel
In vivo prevention of transpla ...... nded human regulatory T cells.
@ast
In vivo prevention of transpla ...... nded human regulatory T cells.
@en
In vivo prevention of transpla ...... nded human regulatory T cells.
@nl
P2093
P2860
P356
P1433
P1476
In vivo prevention of transpla ...... nded human regulatory T cells.
@en
P2093
Alexandru Schiopu
David P Taggart
Douglas C Wu
Joanna Wieckiewicz
Kathryn J Wood
Satish N Nadig
Shiqiao Luo
P2860
P2888
P304
P356
10.1038/NM.2154
P407
P577
2010-05-16T00:00:00Z